BEAT Stock News 6.98 05/13/2014 15:11:07 Cardionet (BEAT)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cardionet (BEAT) 6.98 $BEAT

Global mHealth Monitoring And Diagnostic Medical Devices Market 2013-2019: Focus On Medical Devices With In-Built Plug-Ins For Connectivity
M2 - Tue May 13, 10:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7zxll5/mhealth) has announced the addition of the "mHealth Monitoring And Diagnostic Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" report to their offering. The mHealth monitoring and diagnostic devices market has been segmented into seven major product types, namely, glucose monitors, blood pressure monitors, pulse oximeters, cardiac monitors, sleep apnea monitors, multi-parameter monitoring devices and others (fetal monitors, neurological monitors) devices. The market for these devices has been extensively analyzed on the basis of factors such as healthcare and monitoring applications, geographic presence and technological developments. The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The mHealth monitoring and diagnostic devices market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019. Geographically, the mHealth monitoring and diagnostic devices market has been segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019 along with the CAGR (%) for the forecast period 2013 to 2019. The study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the mHealth monitoring and diagnostic devices market report comprises a qualitative analysis of the overall market considering the factors determining market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. The mHealth monitoring and diagnostic devices market report also provides a highlight of the competitive landscape of the market, wherein the heat map analysis of the leading players in the market in terms of products offered by the companies has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the mHealth monitoring and diagnostic devices market such as AT&T, Inc., Bayer HealthCare AG, BioTelemetry, Inc. (CardioNet, Inc.), Boston Scientific Corporation, DexCom, Inc., Dr?ger AG, F. Hoffmann La-Roche Ltd., Johnson & Johnson, LifeWatch AG, Masimo Corporation, Medtronic, Inc. and Omron Healthcare. The global mHealth monitoring and diagnostic medical devices market is segmented as follows: mHealth Monitoring and Diagnostic Medical Devices Market, by Product Type - Glucose Monitors - Blood Pressure Monitors - Cardiac Monitors - Pulse Oximeters - Sleep Apnea Monitors - Multi-parameter Monitors - Others Companies Mentioned - Bayer HealthCare AG - BioTelemetry, Inc. (CardioNet, Inc.) - Boston Scientific Corporation - DexCom, Inc. - Dr?ger AG - F. Hoffmann-La Roche Ltd. - FitBit, Inc. - Fora Care Inc. - iHealth Labs, Inc. - Johnson & Johnson - LifeWatch AG - Masimo Corporation - Medisana AG - Medtronic, Inc. - Nonin Medical, Inc. - Omron Healthcare, Inc. - Withings, Inc. For more information visit http://www.researchandmarkets.com/research/7zxll5/mhealth

Top Gainers Pre-Market Notes -- Research on bebe stores, BioTelemetry, Axcelis Technologies, and Nanosphere
PR Newswire - Mon May 12, 10:30AM CDT
On Friday, May 9, 2014, the NASDAQ Composite ended at 4,071.87, up 0.50%, the Dow Jones Industrial Average advanced 0.20% to finish the day at 16,583.34, and the S&P 500 closed at 1,878.48, up 0.15%. During the session gains in the Consumer Discretionary, Health Care, and Consumer Staples sectors positively impacted the broader market, while some retraction came in from Utilities, Energy, and Financials sectors. A number of stocks saw large movements, including bebe stores inc. (NASDAQ: BEBE), BioTelemetry Inc. (NASDAQ: BEAT), Axcelis Technologies Inc. (NASDAQ: ACLS) and Nanosphere Inc. (NASDAQ: NSPH). Free technical research on BEBE, BEAT, ACLS and NSPH can be downloaded upon signing up at:

Covance Posts In-line Q1 Earnings; Falls on Trimmed View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 08, 2:30PM CDT
Covance (CVD) reported adjusted earnings per share (EPS) of 90 cents in the first quarter of 2014.

Shares of BEAT Down 25.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu May 08, 9:10AM CDT
SmarTrend identified a Downtrend for CardioNet (NASDAQ:BEAT) on April 10th, 2014 at $9.34. In approximately 4 weeks, CardioNet has returned 25.80% as of today's recent price of $6.93.

Shares of CardioNet Under Pressure, Down 20.6% - May 07, 2014
Comtex SmarTrend(R) - Wed May 07, 9:12AM CDT
CardioNet (NASDAQ:BEAT), a company whose shares are moving quickly, is trading 20.6% lower to $6.88. The S&P is currently trading fractionally higher to 1,869 and the Dow Jones Industrial Average is trading 0.2% higher to 16,441.

How BioTelemetry (BEAT) Stock Stands Out in a Strong Industry - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed May 07, 7:55AM CDT
BioTelemetry might be an intriguing choice for investors as it is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective

BioTelemetry, Inc. Reports First Quarter 2014 Financial Results
GlobeNewswire - Tue May 06, 3:24PM CDT
BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2014.

Weakness Seen in The Spectranetics Corporation (SPNC) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:44AM CDT
The Spectranetics Corporation has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month

PAREXEL Q3 Earnings & Revs Beat Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 2:00PM CDT
For fiscal 2014, PAREXEL International Corporation (PRXL) increased its adjusted EPS guidance to a range of $2.11 to $2.15 from the prior range of $2.01 to $2.11.

BioTelemetry, Inc. to Release First Quarter 2014 Earnings Results on May 6, 2014
GlobeNewswire - Wed Apr 30, 9:52AM CDT
BioTelemetry, Inc. (Nasdaq:BEAT) will release its first quarter 2014 earnings on Tuesday, May 6, 2014 at 4:00 PM Eastern Time.

Omnicare Q1 Earnings Beat by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 1:30PM CDT
Omnicare Inc. (OCR) reported an earnings beat and in-line revenues for the first quarter of 2014, with both increasing on year-over-year bases.

Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

11.0% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Tue Apr 08, 11:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 3rd, 2014 at $8.82. In approximately 2 months, CardioNet has returned 11.00% as of today's recent price of $9.79.

CardioNet Shares Up 17.8% Since SmarTrend's Buy Recommendation (BEAT)
Comtex SmarTrend(R) - Tue Apr 01, 9:59AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 3rd, 2014 at $8.82. In approximately 2 months, CardioNet has returned 17.80% as of today's recent price of $10.39.

BioTelemetry, Inc. Announces the Acquisition of the Cardiac Patient Services Business of Biomedical Systems, Corp.
GlobeNewswire - Thu Mar 20, 7:14AM CDT
BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that it has entered into a definitive agreement to acquire the cardiac patient services business of Biomedical Systems, Corp. ("BMS" for aggregate consideration of $8.65 million at closing. Post integration, the acquisition is expected to generate $8.0 to $9.0 million in revenue and $2.5 to $3.0 million in EBITDA on an annualized basis. The transaction is expected to close in early April.

CardioNet Up 15.5% Since SmarTrend Uptrend Call (BEAT)
Comtex SmarTrend(R) - Mon Mar 17, 5:33PM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 3rd, 2014 at $8.82. In approximately 1 month, CardioNet has returned 15.53% as of today's recent price of $10.19.

CardioNet Earnings In Retrospect: Up 4.9% in the Last 19 Days (BEAT)
Comtex SmarTrend(R) - Mon Mar 17, 7:10AM CDT
Two weeks ago on February 26th, 2014 CardioNet (NASDAQ:BEAT) reported earnings and analysts, on average, expected a loss of $0.02 on sales of $32.3 million. CardioNet actually reported earnings of $0.05 per share on sales of $33.1 million, beating EPS estimates by $0.07 and beating revenue estimates by $0.8 million. Since the company's report, shares of CardioNet have risen from $9.85 to $10.33, representing a gain of 4.9% in the past 19 days.

BioTelemetry (BEAT): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:33AM CDT
BioTelemetry belongs to the Medical Services industry, will be a decent pick, as the company witnessed solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 129

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 42

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 343

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

Anticipating NeuroOne's Q2 Financial Insights and Growth Strategies

Updated Category News Views 124

NeuroOne Prepares to Release Second Quarter Fiscal Financial Results EDEN PRAIRIE, Minn. — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is set to unveil its financial performance for the fiscal second quarter. The reporting period ended on March 31, and the results will be publicized before market activities commence on May 13. This is an exciting time for...

Continue Reading
FNB's Grand Plan for Ultra-Rich Wealth Clients

Updated Category News Views 79

FNB Corporation's New Strategy Sparks Interest Ah, the ever-competitive world of financial services targets the well-heeled once again. FNB Corporation (NYSE: FNB), headquartered in Pittsburgh, is rolling up its sleeves to offer something new for ultra-high-net-worth clientele. Outside Wall Street's dizzying chaos, this quiet yet aggressive move seems to signal they're up...

Continue Reading
Brazil Stock Market Trends and Key Indicators Update

Updated Category News Views 300

Brazil Stock Market Overview Recently, Brazil's stock market showed signs of decline, particularly on a Thursday when the Bovespa index dropped by 0.79%, reaching a new three-month low. This downturn was primarily driven by losses in critical sectors such as Public Utilities, Electric Power, and Real Estate. Investors and market analysts closely monitor these trends as...

Continue Reading
NEXN Stock Reaches New Heights Amid Positive Market Trends

Updated Category News Views 159

NEXN Stock Hits New Milestone NEXN stock has recently hit a significant milestone, reaching a price of $8.34. This impressive peak is not just a reflection of the company’s strong performance but also highlights a period filled with optimism in the market. With investors closely monitoring the stock's path, this new high may point to a potential sustained upward trend...

Continue Reading
Total Voting Rights Update from PayPoint Plc

Updated Category News Views 108

Understanding PayPoint Plc's Total Voting Rights PayPoint Plc has recently provided an update regarding its voting rights and share capital, which is crucial information for shareholders and those interested in the company. Total Share Capital Information As of August 31, 2024, PayPoint Plc's share capital consists of 72,342,171 ordinary shares, each valued at 1/3 pence....

Continue Reading